XML 42 R21.htm IDEA: XBRL DOCUMENT v3.20.1
Note 1 - Description of Business and Basis of Presentation (Details Textual)
3 Months Ended 12 Months Ended
Jun. 04, 2019
Jan. 01, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
shares
Mar. 31, 2020
USD ($)
shares
Nov. 26, 2019
USD ($)
Jun. 30, 2019
shares
Mar. 31, 2017
USD ($)
Number of Reportable Segments       2        
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance       $ 530,000 $ 389,000      
Reorganization of Subsidiary and Related Change in Non-controlling Interest              
Common Stock, Shares Authorized (in shares) | shares       350,000,000 350,000,000   350,000,000  
Cash and Cash Equivalents, at Carrying Value, Ending Balance       $ 3,157,000 $ 5,719,000      
Working Capital         6,914,000      
Retained Earnings (Accumulated Deficit), Ending Balance       $ (236,932,000) (241,534,000)      
Boyalife Investment Fund II, Inc. [Member] | Revolving Credit Facility [Member]                
Line of Credit Facility, Maximum Borrowing Capacity         10,000,000     $ 10,000,000
Long-term Line of Credit, Total         $ 7,582,000      
Reverse Stock Split [Member]                
Stockholders' Equity Note, Stock Split, Conversion Ratio 10              
ImmuneCyte [Member]                
Equity Method Investment, Ownership Percentage       18.87% 18.87% 20.00%    
Line of Credit Facility, Maximum Borrowing Capacity           $ 1,000,000    
ImmuneCyte [Member] | HealthBanks Biotech [Member]                
Equity Method Investment, Ownership Percentage       75.47%   80.00%    
Noncontrolling Interest [Member]                
Reorganization of Subsidiary and Related Change in Non-controlling Interest   $ 2,843,000 $ 2,843,000          
CAR-TXpress [Member]                
Noncontrolling Interest, Ownership Percentage by Parent   80.00%   80.00% 80.00%      
Minority Interest Acquired Through Exchange   20.00%            
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance   $ 1,100,000            
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners         20.00%      
ThermoGenesis [Member]                
Noncontrolling Interest, Ownership Percentage by Parent   100.00%            
Ownership in Subsidiary Exchanged   20.00%            
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance   $ (1,711,000)